AHL Partners’s Omnicell OMCL Stock Holding History

AHL Partners’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-25,385	Closed	-$1.3M	–	1335
2017 Q3	$1.3M	Buy	+25,385	New	+$1.22M	0.02%	811
2016 Q4	–	Sell	-5,245	Closed	-$201K	–	1146
2016 Q3	$201K	Buy	+5,245	New	+$196K	0.01%	1093

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AHL Partners's OMCL Position: Q4 2017 in Review

AHL Partners sold out of Omnicell (OMCL) in Q4 2017, closing a stake of 25,385 shares — an estimated $1.3M sold.

AHL Partners first reported a position in OMCL in Q3 2016 and held it in 2 quarters. The position peaked at $1.3M in Q3 2017. 227 funds tracked by Wall St. Rank hold OMCL as of Q4 2017.

AHL Partners reported no remaining Omnicell position as of Q4 2017 after selling out during the quarter.
AHL Partners sold 25,385 Omnicell shares in Q4 2017, an estimated $1.3M.
AHL Partners first reported a position in Omnicell in Q3 2016 and held it in 2 quarters.
AHL Partners's Omnicell position peaked at $1.3M in Q3 2017.
227 funds tracked by Wall St. Rank held Omnicell as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.